ロード中...
The next forum for unraveling FDA off-label marketing rules: State and federal legislatures
In a Guest Editorial, Aaron S. Kesselheim and Michael S. Sinha show how federal and state legislation to allow promotion of drugs for non-approved uses threatens to undermine the FDA's public health mission.
保存先:
| 出版年: | PLoS Med |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5940176/ https://ncbi.nlm.nih.gov/pubmed/29738523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1002564 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|